![Accelerated Development of a Scalable Ring-Closing Metathesis to Manufacture AMG 176 Using a Combined High-Throughput Experimentation and Computational Modeling Approach | Organic Process Research & Development Accelerated Development of a Scalable Ring-Closing Metathesis to Manufacture AMG 176 Using a Combined High-Throughput Experimentation and Computational Modeling Approach | Organic Process Research & Development](https://pubs.acs.org/cms/10.1021/acs.oprd.0c00416/asset/images/large/op0c00416_0004.jpeg)
Accelerated Development of a Scalable Ring-Closing Metathesis to Manufacture AMG 176 Using a Combined High-Throughput Experimentation and Computational Modeling Approach | Organic Process Research & Development
![Amgen To Highlight New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting Amgen To Highlight New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting](https://mma.prnewswire.com/media/213782/amgen_logo.jpg?p=facebook)
Amgen To Highlight New Preclinical Data At The American Association For Cancer Research (AACR) Annual Meeting
![Cancers | Free Full-Text | Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma Cancers | Free Full-Text | Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma](https://www.mdpi.com/cancers/cancers-14-03330/article_deploy/html/images/cancers-14-03330-g001.png)
Cancers | Free Full-Text | Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma
![Frontiers | Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia Frontiers | Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia](https://www.frontiersin.org/files/Articles/833714/fonc-12-833714-HTML/image_m/fonc-12-833714-g003.jpg)
Frontiers | Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia
![StudyPages - First in-Human Trial of the Experimental Drug AMG 176 in Relapsed or Refractory (re-occurring) Cancer of the Blood Systems StudyPages - First in-Human Trial of the Experimental Drug AMG 176 in Relapsed or Refractory (re-occurring) Cancer of the Blood Systems](https://yuzu-studypages-prod-east.s3.amazonaws.com/study_banners/1190.jpg)
StudyPages - First in-Human Trial of the Experimental Drug AMG 176 in Relapsed or Refractory (re-occurring) Cancer of the Blood Systems
![Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation - ScienceDirect Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379123000320-gr3.jpg)
Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation - ScienceDirect
![Frontiers | Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia Frontiers | Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia](https://www.frontiersin.org/files/MyHome%20Article%20Library/833714/833714_Thumb_400.jpg)
Frontiers | Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia
![Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy | Signal Transduction and Targeted Therapy Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00361-x/MediaObjects/41392_2020_361_Fig1_HTML.png)
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy | Signal Transduction and Targeted Therapy
![Updates and rationale of clinical trials in multiple myeloma - Branagan - 2019 - ADVANCES IN CELL AND GENE THERAPY - Wiley Online Library Updates and rationale of clinical trials in multiple myeloma - Branagan - 2019 - ADVANCES IN CELL AND GENE THERAPY - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d493d907-e41e-42e7-88e9-62a45e44f45b/acg259-fig-0001-m.jpg)